The broad-spectrum fifth-generation cephalosporin antibiotic, Zevtera (Ceftobiprole medocaril sodium Inj.) has been approved by FDA1 for the treatment of three diseases viz.
Staphylococcus aureus bloodstream infections...
BX795 is a newly developed broad-spectrum anti-viral drug candidate which can treat infections from Herpes Simplex Virus-1 and possibly from other viruses in both...